Waist circumference is a strong and independent determinant of the distribution of HDL subfractions inoverweight patients with cardiovascular risk factors

Diabetes and Vascular Disease Research

Volumn 9, Issue 2, 2012, Pages 153-159

  Rosenbaum, David ^a,b,c   Hansel, Boris ^a,b,c   Bonnefont Rousselot, Dominique ^a,b   Bittar, Randa ^a,b,c   Girerd, Xavier ^a,b,c   Giral, Philippe ^a,b,c   Bruckert, Eric ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

HDL subfractions; LDL subfractions; Metabolic syndrome; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2A; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN 3A; HIGH DENSITY LIPOPROTEIN 3B; HIGH DENSITY LIPOPROTEIN 3C; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN 1; LOW DENSITY LIPOPROTEIN 2; LOW DENSITY LIPOPROTEIN 3; LOW DENSITY LIPOPROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; PARIS; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84861069161     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164111431990     Document Type: Article

References (32)

1. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology andPrevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolicsyndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology andPrevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
2. Hulthe J, Bokemark L, Wikstrand J, et al. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 2000; 20: 2140-2147.
3. Pascot A and Lemieux I. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 2001; 42: 2007-2014. (Pubitemid 34001049)
4. Solymoss BC, Bourassa MG, Campeau L, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93: 159-164. (Pubitemid 38058723)
5. Medina-Urrutia A, Juarez-Rojas JG, Martinez-Alvarado R, et al. High-density lipoprotein subclasses distribution andcomposition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and C-reactive protein. Atherosclerosis 2008; 201: 392-397.
6. Palaniappan LP, Kwan AC, Abbasi F, et al. Lipoproteinabnormalities are associated with insulin resistance in South Asian Indian women. Metabolism 2007; 56: 899-904. (Pubitemid 46890971)
7. Goff Jr DC, D'Agostino Jr RB, Haffner SM, et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54: 264-270. (Pubitemid 40174857)
8. Allain CC, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
9. Fossati P and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-2080. (Pubitemid 12034053)
10. Egloff M, Leglise D, Duvillard L, et al. Multicenter evaluation on different analyzers of three methods for direct HDLcholesterol assay. Ann Biol Clin (Paris) 1999; 57: 561-572. (Pubitemid 29457398)
11. Bayer P, Veinberg F, Couderc R, et al. Multicenter evaluation of four homogenous LDL-cholesterol assays. Ann BiolClin (Paris) 2005; 63: 27-41. (Pubitemid 40225031)
12. Krauss RM and Blanche PJ. Detection and quantification of LDL subfractions. Clin Chem 1992; 3: 377-383.
13. Blanche PJ, Gong EL, Forte TM, et al. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981; 665: 408-419. (Pubitemid 11011381)
14. Vekic J, Zeljkovic A, Jelic-Ivanovic Z, et al. Small, dense LDL and apolipoprotein B: Relationship with serum lipids and LDL size. Atherosclerosis 2009; 207: 496-501.
15. Yusuf S, Hawken S, Ounpuu S, et al. on behalf of the INTERHEART Study Investigators. Obesity and the risk ofmyocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649. (Pubitemid 41552419)
16. Wilson, HM, Patel JC and Skinner ER. The distribution ofhigh-density lipoprotein subfractions in coronary survivors. Biochem Soc Trans 1990 18: 1175-1176.
17. Johansson J, Carlson LA, Landou C, et al. High-density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991 11: 174-182.
18. Kontush A and Chapman MJ. Functionally defective highdensity lipoprotein: a new therapeutic target at the crossroads of dyslipidimia, inflammation and atherosclerosis. Pharmacol Rev 2006; 58: 342-374. (Pubitemid 44394906)
19. Verges B. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol 2009; 23: 681-685.
20. Srinivasan SR, Li S, Chen W, Boerwinkle E and Berenson GS. R219K polymorphism of the ABCA1 gene and its modulation of the variations in serum high-density lipoprotein cholesterol and triglycerides related to age and adiposity in white versus black young adults. The Bogalusa Heart Study. Metabolism 2003; 52: 930-934. (Pubitemid 36949559)
21. Satoh H, Saijo Y, Yoshioka E and Tsutsui H. Helicobacter pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb 2010; 17:1041-1048.
22. Festa A, Williams K, Hanley AJ, et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005; 111: 3465-3472. (Pubitemid 40923401)
23. Srinivasan SR, Segrest JP, Elkasabany AM, et al. Distributionand correlates of lipoproteins and their subclasses in black and white young adults. The Bogalusa Heart Study.Atherosclerosis 2001; 159: 391-397. (Pubitemid 33127252)
24. Gazi IF, Filippatos TD, Tsimihodimos V, et al. The hypertriglyceridemicwaist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 2006; 41: 647-654. (Pubitemid 44547679)
25. Rainwater DL, Mitchell BD, Comuzzie AG, et al.Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord 1999; 23: 180-189. (Pubitemid 29057514)
26. Kontush A and Chapman MJ. Antiatherogenic small, dense HDL - guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 2006; 3: 144-153.
27. Castle CK, Kuiper SL, Blake WL, et al. Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein. Am J Physiol 1998; 274: 1091-1098.
28. Dullaart RP, Sluiter WJ, Dikkeschei LD, et al. Effect of adiposity on plasma lipid transfer protein activities: a possiblelink between insulin resistance and high-density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-194. (Pubitemid 24197267)
29. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma. Diabetologia 2003; 46: 459-469.
30. Matsuzaw Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.Atheroscler Suppl 2005; 6: 7-14.
31. Kobayashi J, Kusunoki M, Murase Y, et al. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res 2005; 37: 505-509. (Pubitemid 41306401)
32. Weiss R, Otvos JD, Flyvbjerg A, et al. Adiponectin and lipoprotein particle size. Diabetes Care 2009; 32: 1317-1319.